Lasting immune memory against hepatitis B in children after primary immunization with 4 doses of DTPa-HBV-IPV/Hib in the first and 2nd year of life

BMC Infectious Diseases

Volumn 10, Issue , 2010, Pages

  Steiner, Michael ^a   Ramakrishnan, Gunasekaran ^b   Gartner, Britta ^c   Van Der Meeren, Olivier ^d   Jacquet, Jeanne Marie ^d   Schuster, Volker ^e  

^a Medical Practice ^*  (Germany)

^b GlaxoSmithKline Pharmaceuticals Ltd   (India)

^c GLAXOSMITHKLINE   (Germany)

^d GLAXOSMITHKLINE BIOLOGICALS   (Belgium)

^e UNIVERSITY HOSPITAL LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA PERTUSSIS POLIOMYELITIS TETANUS HAEMOPHILUS INFLUENZAE TYPE B HEPATITIS B VACCINE; HEPATITIS B ANTIBODY; HEPATITIS B VACCINE; INFANRIX HENXA; RECOMBINANT HEPATITIS B VACCINE; UNCLASSIFIED DRUG; BACTERIUM ANTIBODY; DIPHTHERIA PERTUSSIS TETANUS VACCINE; HAEMOPHILUS VACCINE; POLIOMYELITIS VACCINE; VACCINE; VIRUS ANTIBODY;

ABSENCE OF SIDE EFFECTS; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY RESPONSE; ARTICLE; CHILD; CLINICAL ASSESSMENT; HEPATITIS B; HUMAN; HUMAN EXPERIMENT; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; IMMUNOLOGICAL MEMORY; NORMAL HUMAN; PRESCHOOL CHILD; VACCINATION; ANTIBODY PRODUCTION; BLOOD; CLINICAL TRIAL; FEMALE; FOLLOW UP; GERMANY; IMMUNOLOGY; MALE; MULTICENTER STUDY;

ANTIBODIES, BACTERIAL; ANTIBODIES, VIRAL; ANTIBODY FORMATION; CHILD, PRESCHOOL; DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINES; FEMALE; FOLLOW-UP STUDIES; GERMANY; HAEMOPHILUS VACCINES; HUMANS; IMMUNIZATION, SECONDARY; IMMUNOLOGIC MEMORY; MALE; POLIOVIRUS VACCINE, INACTIVATED; VACCINES, COMBINED;

EID: 76749128958     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-10-9     Document Type: Article

References (20)

1. World Health Organization Hepatitis B vaccines WHO position paper. WER 2004, 79:255-263. World Health Organization.
2. World Health Organization Progress in the control of viral hepatitis: memorandum from a WHO meeting. Bull WHO 1988, 66:443-455. 2491173, 2971466, World Health Organization.
3. Lawrence MH, Goldstein MA. Hepatitis B immunization in adolescents. J Adolesc Health 1995, 17:234-243. 10.1016/1054-139X(95)00165-O, 8580124.
4. Centers for Disease Control and Prevention Hepatitis B Virus: A comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination: Recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR 1991, 40(RR-13):1-19. Centers for Disease Control and Prevention.
5. Brabin L, Greenberg DP, Hessel L, Hyer R, Ivanoff B, Van Damme P. Current issues in adolescent immunization. Vaccine 2008, 26:4120-34. 10.1016/j.vaccine.2008.04.055, 18617295.
6. Heininger U, Loos K, Lorenz I, Rascher W. Compliance with recommended immunizations in adolescents. Eur J Pediatr 2006, 165:671-676. 10.1007/s00431-006-0161-9, 16705466.
7. Vandermeulen C, Roelants M, Theeten H, Depoorter AM, Van Damme P, Hoppenbrouwers K. Vaccination coverage in 14-year-old adolescents: documentation, timeliness, and sociodemographic determinants. Pediatrics 2008, 121:e428-434. 10.1542/peds.2007-1415, 18310163.
8. Freed GL, Cowan AE, Clark SJ, Santoli J, Bradley J. Use of a new combined vaccine in pediatric practices. Pediatrics 2006, 118:e251-257. 10.1542/peds.2006-0114, 16831895.
9. Kalies H, Grote V, Verstraeten T, Hessel L, Schmitt HJ, von Kries R. The use of combination vaccines has improved timeliness of vaccination in children. Pediatr Infect Dis J 2006, 25:507-512. 10.1097/01.inf.0000222413.47344.23, 16732148.
10. Zepp F, Schmitt J, Cleerbout J, Verstraeten T, Schuerman L, Jacquet J-M. Review of eight years of experience with Infanrix hexa (DTPa-HBV-IPV/Hib hexavalent vaccine). Exp Rev Vaccines 2009, 8:663-679.
11. Lim FS, Han HH, Jacquet JM, Bock HL. Primary vaccination of infants against hepatitis B can be completed using a combined hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliomyelitis-Haemophilus influenzae type B vaccine. Ann Acad Med Singapore 2007, 36:801-806.
12. Cambron P, Jacquet J-M, Hoet B, Lievens M. Development and Technical and Clinical Validation of a Quantitative Enzyme-Linked Immunosorbent Assay for the Detection of Human Antibodies to Hepatitis B Surface Antigen in Recipients of Recombinant Hepatitis B Virus Vaccine. Clin Vacc Immunol 2009, 16:1236-1246.
13. Heininger U, , . DTP-HBV-IPV-059 Study Group, DTP-HBV-IPV-096 Study Group Booster immunization with a hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated poliovirus vaccine and Haemophilus influenzae type b conjugate combination vaccine in the second year of life: safety, immunogenicity and persistence of antibody responses. Vaccine 2007, 25:1055-1063. 10.1016/j.vaccine.2006.09.060, 17049692, DTP-HBV-IPV-059 Study Group, DTP-HBV-IPV-096 Study Group.
14. Zinke M, Kappes R, Kindler K, Paulus-Koschik A, Goering U, Disselhoff J, Soemantri P, Grunert D, Laakmann H, Gunasekaran R, Gartner B, Jacquet J-M. Immune memory to hepatitis B virus in 4-to-9-year old children vaccinated in infancy with four doses of hexavalent DTPa-HBV-IPV/Hib vaccine. Human Vaccines 2009, 5:592-598.
15. Giambi C, Bella A, Barale A, Montu D, Marchisio M, Oddone M, Zito S, Rapicetta M, Chionne P, Madonna E, degli Atti ML. A cohort study to evaluate persistence of hepatitis B immunogenicity after administration of hexavalent vaccines. BMC Infect Dis 2008, 8:100. 10.1186/1471-2334-8-100, 2527316, 18662386.
16. World Health Organization Core information for the development of immunization policy. Document WHO/V&B/02.28, 2002 2002, Geneva, WHO, World Health Organization.
17. European Consensus Group on Hepatitis B Immunity Are booster immunisations needed for lifelong hepatitis B immunity?. Lancet 2000, 355:561-565. 10.1016/S0140-6736(99)07239-6, 10683019, European Consensus Group on Hepatitis B Immunity.
18. Alfaleh F, Alshehri S, Alansari S, Aljeffri M, Almazrou Y, Shaffi A, Abdo AA. Long-term protection of hepatitis B vaccine 18 years after vaccination. J Infect 2008, 57:404-409. 10.1016/j.jinf.2008.08.008, 18829116.
19. Sande MA, Waight PA, Mendy M, Zaman S, Kaye S, Sam O, Kahn A, Jeffries D, Akum AA, Hall AJ, Bah E, McConkey SJ, Hainaut P, Whittle HC. Long-term protection against HBV chronic carriage of Gambian adolescents vaccinated in infancy and immune response in HBV booster trial in adolescence. PLoS ONE 2007, 2:e753. 10.1371/journal.pone.0000753, 1940311, 17710152.
20. Van Damme P, Van Herck K. A review of the long-term protection after hepatitis A and B vaccination. Travel Med Infect Dis 2007, 5:79-84. 10.1016/j.tmaid.2006.04.004, 17298912.